Header Logo

Joel Block

Concepts (455)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Osteoarthritis, Knee
20
2021
169
4.430
Why?
Lupus Erythematosus, Systemic
21
2021
100
4.190
Why?
Osteoarthritis
12
2021
168
2.440
Why?
Arthritis, Rheumatoid
13
2020
132
2.350
Why?
Quality of Life
11
2018
261
2.030
Why?
Humans
99
2022
12240
1.940
Why?
Myositis
5
2015
15
1.860
Why?
Creatine Kinase
5
2015
17
1.830
Why?
Knee Joint
12
2019
284
1.730
Why?
Middle Aged
52
2021
4043
1.630
Why?
Osteoarthritis, Hip
8
2020
38
1.620
Why?
Female
61
2021
6974
1.620
Why?
Rheumatic Diseases
4
2021
30
1.520
Why?
Arthralgia
4
2019
56
1.490
Why?
Rheumatology
7
2022
42
1.430
Why?
Male
54
2019
6815
1.380
Why?
Severity of Illness Index
16
2018
423
1.250
Why?
Adult
40
2019
3557
1.240
Why?
Disease Management
3
2021
59
1.200
Why?
Body Image
4
2014
19
1.180
Why?
Gait
12
2019
195
1.110
Why?
Pain
9
2019
193
1.070
Why?
Arthritis, Psoriatic
3
2017
11
1.040
Why?
Pain Measurement
8
2019
211
1.010
Why?
Surveys and Questionnaires
8
2018
546
0.940
Why?
Rheumatologists
4
2020
13
0.870
Why?
Aspartate Aminotransferases
2
2015
10
0.870
Why?
Alanine Transaminase
2
2015
10
0.870
Why?
Health Status
8
2018
96
0.840
Why?
Hyaluronic Acid
2
2019
23
0.830
Why?
Antirheumatic Agents
5
2020
40
0.810
Why?
Lupus Erythematosus, Cutaneous
2
2014
4
0.810
Why?
Aged
26
2021
4000
0.810
Why?
Antibodies, Monoclonal
4
2017
86
0.780
Why?
Patient Reported Outcome Measures
4
2018
165
0.770
Why?
Muscle Strength
5
2019
46
0.760
Why?
Bone Density
6
2011
110
0.760
Why?
Reproducibility of Results
10
2021
324
0.740
Why?
Arthritis, Infectious
2
2017
32
0.720
Why?
Posterior Leukoencephalopathy Syndrome
1
2021
7
0.700
Why?
Lupus Nephritis
1
2021
15
0.690
Why?
Immunosuppressive Agents
4
2017
61
0.680
Why?
Data Interpretation, Statistical
1
2021
40
0.670
Why?
Shoes
2
2013
13
0.660
Why?
Weight-Bearing
10
2014
72
0.650
Why?
Cartilage, Articular
3
2021
163
0.650
Why?
Research Design
1
2021
79
0.640
Why?
Analgesics
2
2020
48
0.640
Why?
Tuberculosis
3
2009
12
0.640
Why?
Nerve Growth Factor
2
2017
25
0.640
Why?
Leg
4
2008
16
0.640
Why?
Musculoskeletal Pain
1
2020
13
0.620
Why?
Etanercept
4
2017
8
0.620
Why?
Nerve Growth Factors
1
2020
17
0.620
Why?
Analgesics, Non-Narcotic
3
2017
14
0.590
Why?
Cross-Sectional Studies
10
2019
400
0.580
Why?
Vibration
4
2018
18
0.570
Why?
Patient Acuity
1
2018
5
0.560
Why?
Hip Joint
4
2004
136
0.530
Why?
Retrospective Studies
10
2018
1467
0.530
Why?
Treatment Outcome
9
2019
1478
0.510
Why?
Dermatomyositis
2
2014
5
0.510
Why?
Hepatitis C, Chronic
1
2017
18
0.510
Why?
Chondrosarcoma
10
2006
17
0.480
Why?
Mortality, Premature
1
2015
5
0.450
Why?
Prednisone
1
2015
31
0.450
Why?
Methylprednisolone
1
2015
10
0.450
Why?
Joints
3
2008
43
0.450
Why?
Biomechanical Phenomena
7
2013
297
0.440
Why?
Orthotic Devices
3
2010
16
0.440
Why?
Anti-Inflammatory Agents
1
2015
39
0.440
Why?
Adrenal Cortex Hormones
1
2015
55
0.440
Why?
Proprioception
1
2014
8
0.430
Why?
Exercise Therapy
3
2020
42
0.420
Why?
Health Status Indicators
2
2016
38
0.420
Why?
Patient Education as Topic
1
2014
64
0.420
Why?
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
1
2014
1
0.420
Why?
Keratan Sulfate
3
2006
12
0.420
Why?
United States
8
2020
989
0.410
Why?
Fructose-Bisphosphate Aldolase
1
2014
2
0.410
Why?
Acute Kidney Injury
1
2014
25
0.410
Why?
Immunoglobulin G
3
2009
38
0.390
Why?
Foot Orthoses
1
2013
5
0.390
Why?
Vasculitis
2
2009
17
0.390
Why?
Dermatology
1
2012
3
0.380
Why?
Diagnostic Self Evaluation
1
2012
6
0.370
Why?
Radiography
6
2010
258
0.340
Why?
Touch
2
2008
7
0.340
Why?
Synovial Fluid
3
2011
53
0.330
Why?
Benchmarking
1
2010
13
0.320
Why?
Knee
1
2010
16
0.320
Why?
Quadriceps Muscle
1
2010
16
0.320
Why?
Foot
1
2010
17
0.310
Why?
Hand Joints
2
2020
2
0.310
Why?
Demography
1
2010
37
0.310
Why?
Income
1
2010
35
0.310
Why?
Biomarkers
5
2017
294
0.300
Why?
Isoniazid
1
2009
2
0.300
Why?
Transaminases
1
2009
4
0.300
Why?
Methotrexate
1
2009
18
0.300
Why?
Risk Factors
5
2021
1049
0.300
Why?
Psychometrics
5
2018
95
0.290
Why?
Spondylitis, Ankylosing
1
2009
11
0.290
Why?
Liver
1
2009
57
0.290
Why?
Disease Progression
6
2013
290
0.280
Why?
Pilot Projects
3
2014
214
0.270
Why?
Language
3
2021
30
0.270
Why?
Immunoconjugates
1
2008
6
0.270
Why?
Arthritis, Experimental
2
2019
30
0.260
Why?
Range of Motion, Articular
4
2019
278
0.260
Why?
Walking
1
2008
108
0.260
Why?
Dose-Response Relationship, Drug
4
2015
179
0.260
Why?
Cohort Studies
5
2019
827
0.260
Why?
Joint Deformities, Acquired
1
2007
1
0.260
Why?
Reference Values
3
2014
103
0.250
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2006
46
0.240
Why?
Bone Morphogenetic Proteins
1
2006
39
0.230
Why?
Glucocorticoids
3
2018
35
0.230
Why?
Pain Management
3
2018
74
0.230
Why?
Sensory Thresholds
3
2012
13
0.230
Why?
Femur Head Necrosis
1
2005
2
0.220
Why?
Bone Neoplasms
5
2004
59
0.220
Why?
Case-Control Studies
3
2014
256
0.210
Why?
Immunocompromised Host
3
2021
25
0.210
Why?
Polymyositis
2
2014
5
0.210
Why?
Cross-Cultural Comparison
3
2013
20
0.200
Why?
Proteoglycans
3
1994
59
0.200
Why?
Arthroplasty, Replacement, Hip
2
2005
349
0.200
Why?
Risk Assessment
4
2014
295
0.200
Why?
Predictive Value of Tests
3
2018
218
0.200
Why?
Purpura, Thrombotic Thrombocytopenic
1
2003
4
0.200
Why?
Chi-Square Distribution
3
2014
60
0.200
Why?
Diclofenac
1
2003
2
0.190
Why?
Acetaminophen
1
2003
11
0.190
Why?
Aged, 80 and over
5
2019
2152
0.190
Why?
Animals
5
2020
2092
0.190
Why?
Socioeconomic Factors
3
2015
153
0.190
Why?
Kidney
1
2003
87
0.190
Why?
Pneumococcal Infections
1
2021
4
0.180
Why?
Lupus Erythematosus, Discoid
1
2021
4
0.180
Why?
Tumor Necrosis Factor-alpha
3
2008
95
0.170
Why?
Cartilage
2
1992
41
0.170
Why?
Follow-Up Studies
3
2014
726
0.170
Why?
Medication Therapy Management
1
2021
1
0.170
Why?
Patient Care Planning
1
2021
15
0.170
Why?
Internship and Residency
1
2022
103
0.160
Why?
Foundations
1
2020
1
0.160
Why?
Mycobacterium Infections
1
2019
2
0.150
Why?
Mycobacterium haemophilum
1
2019
2
0.150
Why?
Mediastinal Diseases
1
2019
3
0.150
Why?
Chicago
3
2018
453
0.150
Why?
Adjuvants, Immunologic
1
2019
4
0.150
Why?
Injections, Intra-Articular
1
2019
31
0.150
Why?
Azacitidine
1
2019
9
0.150
Why?
Young Adult
4
2015
863
0.150
Why?
Chronic Pain
1
2020
63
0.150
Why?
Absorptiometry, Photon
4
2011
62
0.150
Why?
Enzyme Inhibitors
1
2019
75
0.150
Why?
Practice Guidelines as Topic
1
2020
116
0.150
Why?
Outpatient Clinics, Hospital
1
2018
7
0.140
Why?
Quality Indicators, Health Care
1
2018
13
0.140
Why?
Observer Variation
1
2018
47
0.140
Why?
Delivery of Health Care, Integrated
1
2018
14
0.140
Why?
DNA Methylation
1
2019
93
0.140
Why?
Sleep Wake Disorders
1
2019
58
0.140
Why?
Prognosis
4
2017
363
0.140
Why?
Academic Medical Centers
1
2019
71
0.140
Why?
Antibodies, Antinuclear
2
2017
6
0.140
Why?
Arthroplasty
1
1998
54
0.140
Why?
Hyperalgesia
1
2018
33
0.140
Why?
Time Factors
5
2017
695
0.130
Why?
Liver Function Tests
1
2017
12
0.130
Why?
Age Factors
2
2012
350
0.130
Why?
Sex Factors
4
2018
229
0.130
Why?
Statistics as Topic
1
2017
51
0.130
Why?
Viral Load
1
2017
43
0.130
Why?
United Kingdom
2
2010
23
0.130
Why?
Stress, Mechanical
2
2007
86
0.130
Why?
Unnecessary Procedures
1
2017
16
0.130
Why?
Linear Models
2
2014
115
0.130
Why?
Adolescent
5
2015
989
0.120
Why?
Depression
1
2019
229
0.120
Why?
Arthritis, Juvenile
2
2009
6
0.120
Why?
Mycobacterium tuberculosis
2
2009
11
0.120
Why?
Practice Patterns, Physicians'
1
2017
68
0.120
Why?
Fatigue
1
2016
25
0.120
Why?
Chondrocytes
3
2007
58
0.120
Why?
Safety-net Providers
1
2015
5
0.110
Why?
Pulse Therapy, Drug
1
2015
3
0.110
Why?
Longitudinal Studies
3
2015
651
0.110
Why?
Drug Therapy, Combination
1
2015
76
0.110
Why?
Infusions, Intravenous
1
2015
31
0.110
Why?
Cosmetic Techniques
1
2014
4
0.110
Why?
Physical Examination
2
2022
37
0.110
Why?
Combined Modality Therapy
1
2014
143
0.110
Why?
Patient Outcome Assessment
1
2014
18
0.110
Why?
Churg-Strauss Syndrome
1
2014
1
0.100
Why?
Microscopic Polyangiitis
1
2014
1
0.100
Why?
Immunoglobulin kappa-Chains
1
2014
2
0.100
Why?
Immunoglobulin lambda-Chains
1
2014
2
0.100
Why?
Granulomatosis with Polyangiitis
1
2014
3
0.100
Why?
Interleukin-10
1
2014
11
0.100
Why?
Adaptation, Psychological
1
2014
83
0.100
Why?
Interferon-alpha
1
2014
15
0.100
Why?
Creatinine
1
2014
29
0.100
Why?
B-Lymphocytes
2
2019
25
0.100
Why?
Interleukin-6
1
2014
48
0.100
Why?
Renal Dialysis
1
2014
37
0.100
Why?
Liver Diseases
1
2014
15
0.100
Why?
Tumor Cells, Cultured
8
2004
69
0.100
Why?
Body Height
2
2004
8
0.100
Why?
Cognitive Dysfunction
1
2019
449
0.100
Why?
Abatacept
2
2017
5
0.100
Why?
Receptors, Tumor Necrosis Factor
3
2009
10
0.100
Why?
Cystitis
1
1993
4
0.100
Why?
Models, Biological
2
2011
191
0.100
Why?
Cultural Characteristics
1
2013
14
0.100
Why?
Incidence
1
2014
338
0.090
Why?
Matched-Pair Analysis
1
2012
9
0.090
Why?
Self-Assessment
1
2012
11
0.090
Why?
Self Concept
1
2012
26
0.090
Why?
Tenascin
2
2002
2
0.090
Why?
Sensation Disorders
1
2012
8
0.090
Why?
Antitubercular Agents
2
2009
7
0.090
Why?
Perception
1
2012
42
0.090
Why?
Menisci, Tibial
1
2012
41
0.090
Why?
Tuberculin Test
2
2009
6
0.090
Why?
Clinical Trials as Topic
2
2017
100
0.090
Why?
Immunoglobulin Light Chains
1
2011
2
0.090
Why?
Anterior Cruciate Ligament Injuries
1
2012
80
0.080
Why?
Tendon Injuries
1
2012
81
0.080
Why?
Orthopedic Procedures
1
2012
111
0.080
Why?
Braces
1
2010
9
0.080
Why?
Cytokines
1
2011
107
0.080
Why?
Teaching
2
2022
29
0.080
Why?
Pressure
1
2010
24
0.080
Why?
Sickness Impact Profile
1
2010
6
0.080
Why?
Social Environment
1
2010
38
0.080
Why?
Turkey
2
2013
4
0.080
Why?
Educational Status
1
2010
130
0.080
Why?
Self Report
3
2015
94
0.070
Why?
Extremities
1
2008
10
0.070
Why?
Prospective Studies
2
2011
817
0.070
Why?
Adalimumab
2
2019
10
0.070
Why?
Rituximab
1
2008
19
0.070
Why?
Antibodies, Monoclonal, Murine-Derived
1
2008
15
0.070
Why?
T-Lymphocytes
1
2008
50
0.070
Why?
Disability Evaluation
2
2019
105
0.060
Why?
Gene Expression Profiling
2
2004
63
0.060
Why?
Protein Kinase C-delta
1
2007
5
0.060
Why?
Matrix Metalloproteinase 13
1
2007
13
0.060
Why?
Fibroblast Growth Factor 2
1
2007
7
0.060
Why?
Mitogen-Activated Protein Kinases
1
2007
23
0.060
Why?
RNA, Messenger
2
2004
157
0.060
Why?
Activities of Daily Living
1
2008
182
0.060
Why?
Prevalence
2
2016
175
0.060
Why?
Microscopy, Atomic Force
1
2006
4
0.060
Why?
Canada
2
2018
21
0.060
Why?
Image Processing, Computer-Assisted
1
2007
73
0.060
Why?
Body Weight
2
2006
72
0.060
Why?
DNA, Neoplasm
2
2004
9
0.060
Why?
Exercise Test
1
2006
62
0.060
Why?
Autoantigens
1
2006
10
0.060
Why?
Bone Morphogenetic Protein 7
1
2006
16
0.060
Why?
Emotions
2
2017
32
0.060
Why?
Body Mass Index
2
2006
221
0.060
Why?
Signal Transduction
1
2007
246
0.060
Why?
Tibia
1
2006
100
0.060
Why?
Double-Blind Method
2
2003
166
0.060
Why?
Alcoholism
1
2005
34
0.050
Why?
Oligonucleotide Array Sequence Analysis
1
2004
33
0.050
Why?
Cell Transformation, Neoplastic
1
2004
15
0.050
Why?
Hypoxia
1
2004
14
0.050
Why?
Vascular Endothelial Growth Factor A
1
2004
41
0.050
Why?
Abstracting and Indexing as Topic
1
2004
1
0.050
Why?
MEDLINE
1
2004
1
0.050
Why?
Therapeutic Irrigation
1
2004
27
0.050
Why?
Biopsy, Fine-Needle
1
2004
26
0.050
Why?
Terminology as Topic
1
2004
15
0.050
Why?
Transcription Factors
1
2004
105
0.050
Why?
Randomized Controlled Trials as Topic
1
2004
128
0.050
Why?
Tuberculosis, Gastrointestinal
1
2003
2
0.050
Why?
Peritonitis
1
2003
10
0.050
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2001
19
0.050
Why?
Femur Head
1
2003
20
0.050
Why?
Biopsy
1
2003
97
0.050
Why?
Treatment Failure
1
2003
58
0.050
Why?
Magnetic Resonance Imaging
1
2005
464
0.050
Why?
Internal Medicine
1
2022
13
0.050
Why?
Antigens, Neoplasm
1
2002
22
0.040
Why?
Cells, Cultured
4
2007
275
0.040
Why?
Neoplasm Proteins
1
2002
28
0.040
Why?
Vaccination
1
2021
9
0.040
Why?
Fibronectins
1
2001
10
0.040
Why?
Clinical Competence
1
2022
96
0.040
Why?
Alendronate
1
2001
4
0.040
Why?
Cyclin-Dependent Kinases
1
2001
5
0.040
Why?
Retinoblastoma Protein
1
2001
5
0.040
Why?
Adaptation, Physiological
1
2001
29
0.040
Why?
Proto-Oncogene Proteins
1
2001
21
0.040
Why?
Spinal Fractures
1
2001
25
0.040
Why?
Analysis of Variance
1
2000
125
0.040
Why?
Lymph Nodes
1
2019
38
0.040
Why?
Gene Silencing
1
2019
15
0.040
Why?
Chromatin Immunoprecipitation
1
2019
14
0.040
Why?
Flow Cytometry
1
2019
49
0.040
Why?
Autoimmune Diseases
1
2019
16
0.040
Why?
Diagnosis, Differential
1
2019
151
0.040
Why?
Hip
1
1999
16
0.040
Why?
Femur Neck
1
1999
11
0.040
Why?
Mentors
1
2019
16
0.040
Why?
Asia
1
2018
6
0.040
Why?
Europe
1
2018
21
0.040
Why?
Arthroplasty, Replacement, Knee
1
2002
264
0.040
Why?
Morbidity
1
2018
33
0.040
Why?
Appointments and Schedules
1
2018
6
0.040
Why?
Sex Distribution
1
2018
34
0.040
Why?
Biomedical Research
1
2019
27
0.040
Why?
Workload
1
2018
12
0.040
Why?
Somatosensory Disorders
1
2018
5
0.040
Why?
Faculty, Medical
1
2019
34
0.030
Why?
Aging
1
2003
680
0.030
Why?
Independent Living
1
2019
137
0.030
Why?
Disease Models, Animal
1
2019
338
0.030
Why?
Blood Sedimentation
1
2017
26
0.030
Why?
Health Care Surveys
1
2017
39
0.030
Why?
Mental Health
1
2017
47
0.030
Why?
Sleep Initiation and Maintenance Disorders
1
2017
45
0.030
Why?
Illinois
1
2017
110
0.030
Why?
Osteonecrosis
1
2017
9
0.030
Why?
Drug Evaluation, Preclinical
1
2017
18
0.030
Why?
Exercise
1
2019
233
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2017
40
0.030
Why?
Mice
1
2019
760
0.030
Why?
Schizosaccharomyces pombe Proteins
1
1996
1
0.030
Why?
Genes, Tumor Suppressor
1
1996
5
0.030
Why?
Endopeptidases
1
1996
12
0.030
Why?
Checklist
1
2016
16
0.030
Why?
Cost of Illness
1
2016
24
0.030
Why?
Carrier Proteins
1
1996
45
0.030
Why?
Sleep
1
2017
155
0.030
Why?
Multivariate Analysis
1
2016
141
0.030
Why?
Chromatography, Ion Exchange
2
1994
3
0.030
Why?
Software
1
2015
26
0.030
Why?
Physicians
1
2015
43
0.030
Why?
Goals
1
2014
24
0.030
Why?
Arthrography
2
2006
12
0.030
Why?
Collagen
1
1994
44
0.030
Why?
Translations
1
2013
2
0.020
Why?
Polymerase Chain Reaction
2
2004
57
0.020
Why?
Culture
1
2013
10
0.020
Why?
Factor Analysis, Statistical
1
2013
26
0.020
Why?
Polyarteritis Nodosa
1
1993
1
0.020
Why?
Necrosis
1
1993
10
0.020
Why?
Hemorrhage
1
1993
30
0.020
Why?
Gene Expression Regulation, Neoplastic
2
2004
60
0.020
Why?
Philippines
1
2013
3
0.020
Why?
Phenotype
3
2004
157
0.020
Why?
Immunohistochemistry
2
2003
171
0.020
Why?
Chondroitin Lyases
1
1992
1
0.020
Why?
Chymotrypsin
1
1992
2
0.020
Why?
Chromatography, Gel
1
1992
3
0.020
Why?
Trypsin
1
1992
4
0.020
Why?
Electrochemistry
1
1992
29
0.020
Why?
Denmark
1
2012
4
0.020
Why?
Sweden
1
2012
7
0.020
Why?
Alternative Splicing
2
2002
8
0.020
Why?
Glycosaminoglycans
1
1991
9
0.020
Why?
Fluorescent Antibody Technique
1
1991
28
0.020
Why?
Metabolism
1
2011
4
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2011
47
0.020
Why?
Cell Line
1
1991
150
0.020
Why?
Tissue Donors
1
2011
42
0.020
Why?
Femoral Neoplasms
1
1990
2
0.020
Why?
Cognition
1
2014
641
0.020
Why?
Interleukin-1beta
1
2007
17
0.020
Why?
Arteries
1
2007
11
0.020
Why?
Risk
2
2004
97
0.020
Why?
Gene Expression Regulation, Enzymologic
1
2007
19
0.020
Why?
Viscosity
1
2006
6
0.020
Why?
Enzyme Activation
1
2007
64
0.020
Why?
Elasticity
1
2006
19
0.020
Why?
Transcription, Genetic
1
2007
53
0.020
Why?
Actins
1
2006
18
0.020
Why?
Neoplasm Invasiveness
1
2006
34
0.020
Why?
Single-Blind Method
1
2006
46
0.020
Why?
Cell Line, Tumor
1
2006
128
0.020
Why?
Posture
1
2006
20
0.020
Why?
Models, Anatomic
1
2006
19
0.010
Why?
Movement
1
2006
58
0.010
Why?
Gene Dosage
1
2004
6
0.010
Why?
Genes, myc
1
2004
8
0.010
Why?
Genome
1
2004
4
0.010
Why?
Child
2
2004
614
0.010
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2004
3
0.010
Why?
Neovascularization, Pathologic
1
2004
15
0.010
Why?
RNA, Small Interfering
1
2004
45
0.010
Why?
Adverse Drug Reaction Reporting Systems
1
2004
3
0.010
Why?
Information Storage and Retrieval
1
2004
2
0.010
Why?
Infliximab
1
2004
7
0.010
Why?
Up-Regulation
1
2004
89
0.010
Why?
Drug Administration Schedule
1
2003
84
0.010
Why?
Biopsy, Needle
1
2003
56
0.010
Why?
Protein Isoforms
1
2002
22
0.010
Why?
Blotting, Western
1
2002
62
0.010
Why?
K562 Cells
1
2002
4
0.010
Why?
Blotting, Northern
1
2002
13
0.010
Why?
Paclitaxel
1
2002
25
0.010
Why?
Base Sequence
1
2002
57
0.010
Why?
Plasma Exchange
1
1982
2
0.010
Why?
Amino Acid Sequence
1
2002
80
0.010
Why?
Molecular Sequence Data
1
2002
100
0.010
Why?
Drug Resistance, Neoplasm
1
2002
42
0.010
Why?
Cell Adhesion
1
2001
22
0.010
Why?
Binding Sites
1
2001
39
0.010
Why?
Cyclin-Dependent Kinase 4
1
2001
1
0.010
Why?
Genes, p16
1
2001
4
0.010
Why?
Chromosome Aberrations
1
2001
12
0.010
Why?
Placebos
1
2001
25
0.010
Why?
Reoperation
1
2002
366
0.010
Why?
Bone Resorption
1
2001
55
0.010
Why?
Purine-Nucleoside Phosphorylase
1
1996
1
0.010
Why?
Chromosome Banding
1
1996
2
0.010
Why?
Chromosomes, Human, Pair 9
1
1996
4
0.010
Why?
Ploidies
1
1996
4
0.010
Why?
DNA Primers
1
1996
30
0.010
Why?
Sequence Deletion
1
1996
7
0.010
Why?
Lumbar Vertebrae
1
1999
182
0.010
Why?
Fees, Medical
1
1975
1
0.010
Why?
Public Opinion
1
1975
1
0.010
Why?
Financing, Organized
1
1975
4
0.010
Why?
Delivery of Health Care
1
1975
62
0.010
Why?
Orchiectomy
1
1994
2
0.010
Why?
Tritium
1
1994
4
0.010
Why?
Sulfur Radioisotopes
1
1994
3
0.010
Why?
Hexuronic Acids
1
1994
4
0.010
Why?
Glucuronic Acid
1
1994
4
0.010
Why?
Sulfates
1
1994
2
0.010
Why?
Alginates
1
1994
5
0.010
Why?
Culture Techniques
1
1994
11
0.010
Why?
Proline
1
1994
5
0.010
Why?
Gels
1
1994
7
0.010
Why?
Microscopy, Electron
1
1994
35
0.010
Why?
Cattle
1
1994
54
0.010
Why?
Clone Cells
1
1990
8
0.000
Why?
Antithrombin III
1
1982
1
0.000
Why?
Plasminogen
1
1982
1
0.000
Why?
Plasmapheresis
1
1982
6
0.000
Why?
Hemostasis
1
1982
7
0.000
Why?
Blood Coagulation Factors
1
1982
10
0.000
Why?
Thrombosis
1
1982
33
0.000
Why?
New York
1
1975
2
0.000
Why?
Financing, Government
1
1975
3
0.000
Why?
Attitude
1
1975
14
0.000
Why?
Consumer Behavior
1
1975
14
0.000
Why?
Block's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (455)
Explore
_
Co-Authors (28)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_